| Description: | Sequence 33 from patent US 6008018. Sequence 7 from patent US 6075124. Sequence 147 from patent US 6077692. Sequence 14 from patent US 6303338. Sequence 33 from patent US 6379923. Sequence 4 from patent US 6420116. Sequence 50 from patent US 6479254. Sequence 4 from patent US 6495128. Sequence 50 from patent US 6495520. Sequence 147 from patent US 6599879. Sequence 25 from patent US 6617129. Sequence 50 from patent US 6635743. Sequence 14 from patent US 6649738. Sequence 147 from patent US 6693077. Sequence 16 from patent US 6734285. Sequence 7 from patent US 6867006. Sequence 14 from patent US 6893870. Sequence 147 from patent US 6903072. Sequence 147 from patent US 6916786. Sequence 4 from patent US 7001595. Sequence 10 from patent US 7008778. Sequence 45 from patent US 7029870. Sequence 16 from patent US 7153942. Sequence 16 from patent US 7186688. Sequence 16 from patent US 7208582. Sequence 12 from patent US 7220557. Sequence 9 from patent US 7223724. Sequence 4 from patent US 7223840. Sequence 147 from patent US 7232667. Sequence 25 from patent US 7351694. Sequence 45 from patent US 7365163. Mammary cancer-specific gene 1. Antimicrobial peptide. Polynucleotides and polypeptides of METH1 and METH2. Apoptosis inducing molecule ii. Vascular endothelial growth factor 2. Apoptosis-inducing molecule II and method of using the same. Therapeutic utilization of horny cell growth factor-2. Human NK-3 related prostate specific gene-1. Chemokine beta-7. Meth1 and Meth2 Polynucleotides and Polypeptides. Keratinocyte Growth Factor-2. Apoptosis Inducing Molecule II and Methods of Use. Vascular endothelial growth factor2. Vascular Endothelial Growth Factor 2. Keratinocyte Growth Factor-2. Therapeutic. Vascular endothelial growth factor 2. Meth1 and Meth2 Polynucleotides and Polypeptides. Vascular Endothelial Growth Factor-2. Vascular Endothelial Growth Factor-2. Sequence 16 from patent US 7402312. Sequence 16 from patent US 7439333. Sequence 9 from patent US 7524501. Sequence 25 from patent US 7892773. Sequence 50 from patent US 7964190. Sequence 16 from patent US 8216569. Sequence 16 from patent US 8206708. Sequence 16 from Patent EP2228389. JP 2009240323-A/10: Vascular Endothelial Growth Factor-2. | |
| Length: | 3974 bp | |
| Found in databases: | nrnl1 | |
| Found in the following 82 patents: | US6008018 (lens, espacenet) US6075124 (lens, espacenet) US6077692 (lens, espacenet) US6303338 (lens, espacenet) US6303338 (lens, espacenet) US6379923 (lens, espacenet) US6379923 (lens, espacenet) US6420116 (lens, espacenet) US6420116 (lens, espacenet) US6479254 (lens, espacenet) US2002064869 (lens, espacenet) US6495128 (lens, espacenet) US6495128 (lens, espacenet) US6495520 (lens, espacenet) US2002081647 (lens, espacenet) US6599879 (lens, espacenet) US6599879 (lens, espacenet) US6617129 (lens, espacenet) US2003022275 (lens, espacenet) US6635743 (lens, espacenet) US6635743 (lens, espacenet) US6649738 (lens, espacenet) US2002127640 (lens, espacenet) US6693077 (lens, espacenet) US6693077 (lens, espacenet) US6734285 (lens, espacenet) US2003028007 (lens, espacenet) US6867006 (lens, espacenet) US2002182200 (lens, espacenet) US6893870 (lens, espacenet) US2004086978 (lens, espacenet) US6903072 (lens, espacenet) US2003077695 (lens, espacenet) US6916786 (lens, espacenet) US2003129687 (lens, espacenet) US7001595 (lens, espacenet) US2003143192 (lens, espacenet) US7008778 (lens, espacenet) US7008778 (lens, espacenet) US7153942 (lens, espacenet) US2003008357 (lens, espacenet) US7186688 (lens, espacenet) US7186688 (lens, espacenet) US7208582 (lens, espacenet) US2003175274 (lens, espacenet) US7220557 (lens, espacenet) US2003092900 (lens, espacenet) US7223724 (lens, espacenet) US7223724 (lens, espacenet) US7223840 (lens, espacenet) US2005004355 (lens, espacenet) US7232667 (lens, espacenet) US7351694 (lens, espacenet) US2004014668 (lens, espacenet) US7365163 (lens, espacenet) US2006148036 (lens, espacenet) JP2001509664 (lens, espacenet) JP2001527412 (lens, espacenet) JP2002501077 (lens, espacenet) JP2002500043 (lens, espacenet) JP2002505873 (lens, espacenet) JP2002504333 (lens, espacenet) JP2002507546 (lens, espacenet) JP2002510974 (lens, espacenet) JP2002529090 (lens, espacenet) JP2003500041 (lens, espacenet) JP2003520572 (lens, espacenet) JP2003528030 (lens, espacenet) JP2004505619 (lens, espacenet) JP2004536579 (lens, espacenet) US7402312 (lens, espacenet) US2005192429 (lens, espacenet) US7439333 (lens, espacenet) US2005176103 (lens, espacenet) US7524501 (lens, espacenet) US2005181979 (lens, espacenet) US7892773 (lens, espacenet) US7964190 (lens, espacenet) US8216569 (lens, espacenet) US8206708 (lens, espacenet) EP2228389 (lens, espacenet) JP2009240323 (lens, espacenet) | |
View these methods in JRC GMO-Matrix
| Event-specific method | |
| Element-specific method | |
| Construct-specific method | |
| Taxon-specific method |
| Record ID | Database | Record description | Record length | Taxon | Method | Amplicon size | Match details |
|---|---|---|---|---|---|---|---|
| NRN_AR096518 | nrnl1 | Sequence 33 from patent US 6008018.... | 3974 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
| NRN_AR096518 | nrnl1 | Sequence 33 from patent US 6008018.... | 3974 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
Related publications:
Petrillo, M., et al. “JRC GMO-Amplicons: A Collection of Nucleic Acid Sequences Related to Genetically Modified Organisms.” Database (Oxford), vol. 2015 bav101, 30 Sep. 2015, doi:10.1093/database/bav101.
Angers-Loustau, A., et al. “Using the EURL GMFF Online Bioinformatics Resources: A how-to Guide for Practical JRC GMO-Matrix and JRC GMO-Amplicons Case Uses.” European Commission, Ispra, JRC101853, 2016.